Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Interpace Biosciences Inc is a growing leader in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. The activities of the company are functioned through two business units. The Interpace Diagnostics business unit which provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services and Interpace Pharma Solutions business supports clinical trials by providing lab testing, data management, project management, and biorepository services to biopharmaceutical companies.
Parsippany, NJ, 07054